Edition:
United Kingdom

TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

5.50USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$5.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
345,563
52-wk High
$17.30
52-wk Low
$4.95

Chart for

About

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $846.68
Shares Outstanding(Mil.): 68.84
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 85.91 32.75
EPS (TTM): -1.95 -- --
ROI: -129.83 1.70 14.60
ROE: -133.51 3.17 16.33

BRIEF-TG Therapeutics Reports Qtrly Loss Per Share Of $0.59

* TG THERAPEUTICS, INC. PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

08 May 2018

Competitors

Earnings vs. Estimates